Heterocyclic inhibitors of mek and methods of use thereof

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/50 (2006.01) A61K 31/44 (2006.01) A61K 31/519 (2006.01) C07D 221/04 (2006.01) C07D 403/02 (2006.01) C07D 471/02 (2006.01) C07D 487/02 (2006.01)

Patent

CA 2546486

Disclosed are compounds of the Formula I and pharmaceutically acceptable salts and prodrugs thereof, wherein R1, R2, R7, R8 and R9, W, X, Y and Z are as defined in the specification. Such compounds are MEK inhibitors and are useful in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals, and inflammatory conditions. Also disclosed are methods of using such compounds in the treatment of hyperproliferative diseases in mammals and pharmaceutical compositions containing such compounds.

L'invention concerne des composés de formule I, ainsi que des sels et des promédicaments pharmaceutiquement acceptables de ces composés. Dans ladite formule, R?1¿, R?2¿, R?7¿, R?8¿ et R?9¿, W, X, Y et Z sont tels que définis dans la description. Ces composés sont des inhibiteurs de MEK et sont utiles dans le traitement des maladies hyperprolifératives, telles que les cancers et les inflammations, et des états inflammatoires, chez des mammifères. L'invention concerne également des méthodes d'utilisation desdits composés dans le traitement des maladies hyperprolifératives chez des mammifères, ainsi que des compositions pharmaceutiques contenant ces composés.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Heterocyclic inhibitors of mek and methods of use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocyclic inhibitors of mek and methods of use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic inhibitors of mek and methods of use thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1685945

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.